Does Kaiser cover GLP-1s for weight loss?
Sometimes. It depends on your region and your plan. Kaiser Permanente is eight regional health plans: Northern California, Southern California, Colorado, Georgia, Hawaii, the Mid-Atlantic, the Northwest and Washington. Each region keeps its own formulary and its own criteria, so a member in Oregon and a member in Los Angeles can get different answers for the same drug.
The two regions with published rules we could read point the same way. Kaiser covers weight-loss GLP-1s when your plan includes a weight-loss drug benefit, and otherwise you pay the cash price. California keeps one exception for people with a BMI of 40 or more.
Kaiser also works differently from Aetna or Cigna. You get your prescription from a Kaiser clinician and fill it at a Kaiser pharmacy, so the clinician applies the criteria before anything reaches the pharmacy counter.
Does Kaiser California cover Wegovy and Zepbound?
Not for weight loss alone in base plans, unless your BMI is 40 or more. Kaiser’s 2025 notice to brokers spelled out the change: from contract renewals on or after January 1, 2025, GLP-1s and other weight-loss drugs were removed from base coverage in California commercial and Individual & Family plans “when those drugs are prescribed solely for the purpose of weight loss for patients with BMI less than 40.”
| Situation | Base plan | With an employer weight-loss rider |
|---|---|---|
| Weight loss, BMI under 40 | Not covered | Can be covered |
| Weight loss, BMI 40 or more | Still covered, citing a California rule | Covered |
| Type 2 diabetes or after a major heart event | Unchanged | Unchanged |
| Individual & Family plan, BMI under 40 | Not covered | No rider available |
Source: Kaiser Permanente California broker notice on 2025 GLP-1 coverage changes (archived copy, July 2025).
Kaiser’s notice offers the rider only to large employers. On a small-group or individual plan with a BMI under 40, you can’t add weight-loss coverage through Kaiser. Kaiser has since taken that notice off its website, and we couldn’t find a newer one, so ask Pharmacy Services to confirm the current rules for your plan.
What Kaiser offers instead
Kaiser’s member flyer says your base plan still includes its weight management care, such as visits with your care team and online programs at kp.org/weight-management. That’s care, not drug coverage.
What does Kaiser Northwest require?
The Northwest region, which covers Oregon and southwest Washington, publishes its criteria in full, and the list of steps is long.
First, your plan must cover medications used for weight loss. The policy says Wegovy is covered for weight loss “ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price.”
If you have that benefit, the steps are long:
- A BMI of 30 or more, or 27 or more with high blood pressure, diabetes or high cholesterol, measured within about the last 30 days.
- A current diet and exercise program.
- At least two older weight-loss drugs that didn’t work after 3 months each, such as phentermine, Qsymia or Contrave, unless you can’t take any of them.
- For Wegovy, a failed trial of Ozempic after that. For Zepbound, at least 6 months on semaglutide and then a review by Kaiser’s bariatric medicine team.
| Rule | Wegovy | Zepbound |
|---|---|---|
| Weight-loss drug benefit | Required | Required |
| BMI | 30, or 27 with a condition | 30, or 27 with a condition |
| Older oral drugs first | At least two, 3 months each | At least two, 3 months each |
| GLP-1 first | Failed trial of Ozempic | 6 months of semaglutide plus bariatric review |
| First approval | 12 months | 12 months |
| Renewal | Every 12 months, needs 5% loss | Every 12 months, needs 5% loss |
Source: Kaiser Permanente Northwest criteria for coverage, Wegovy (effective February 5, 2026) and Zepbound (effective August 7, 2025).
Zepbound for sleep apnea has its own path in the Northwest. It needs severe sleep apnea (an AHI of 30 or more), a BMI of 30 or more, no diabetes, a sleep study from the last 3 years and the same step therapy. Wegovy for heart risk is narrower still: the policy limits it to people aged 55 to 74 without diabetes who had a certain type of heart attack while already taking Ozempic 2 mg.
These are the versions of the policies we could read. Kaiser updates them, so ask your clinician which version applies.
What about other Kaiser regions?
Washington, Colorado, Georgia, Hawaii and the Mid-Atlantic region (Maryland, Virginia and Washington, D.C.) each set their own rules for Kaiser GLP-1 coverage. We didn’t find full criteria documents from those regions, so we won’t guess at them here.
The pattern in California and the Northwest still gives you the right questions to ask:
- Does my plan include a weight-loss drug benefit or rider? Ask HR if you’re on an employer plan.
- If it does, what are my region’s criteria for Wegovy, Zepbound or Foundayo? Kaiser Pharmacy Services or your clinician can tell you.
- If it doesn’t, is there another covered use? Diabetes, heart disease, sleep apnea and MASH are handled separately in every region we checked.
Does Kaiser Medi-Cal cover GLP-1s for weight loss?
No. Medi-Cal drugs run through the state’s Medi-Cal Rx program for every Medi-Cal health plan, Kaiser included. From January 1, 2026, Medi-Cal Rx stopped covering Saxenda, Wegovy and Zepbound “when used for weight loss or weight-loss indications,” and all earlier approvals expired on December 31, 2025.
Medi-Cal still looks at a few uses case by case: Wegovy for heart disease or MASH, Zepbound for sleep apnea, and members under 21. Since April 1, 2026, Wegovy for MASH no longer needs prior approval if the prescription carries the right diagnosis code. Ozempic and other GLP-1s stay covered for type 2 diabetes.
Does Kaiser Senior Advantage cover Wegovy or Zepbound?
Not for weight loss through the plan itself, because Medicare drug plans can’t cover weight-loss drugs. But Kaiser Senior Advantage plans include Part D, so members can use Medicare’s GLP-1 Bridge. For Medicare members, that’s the main route to Kaiser GLP-1 coverage for weight loss, even though Medicare pays, not Kaiser. It costs $50 a month for Wegovy, the Zepbound KwikPen or Foundayo, from July 1, 2026 through December 31, 2027.
You need a BMI of 35 or more, or 30 or 27 with certain conditions. Type 2 diabetes, moderate-to-severe sleep apnea and MASH send you back to your Kaiser plan instead. Ask your Kaiser clinician to start the request.
How does Kaiser compare with other insurers?
At Aetna, UnitedHealthcare and Cigna, your employer decides whether weight-loss GLP-1s are covered, and the insurer applies its prior authorization rules. Kaiser GLP-1 coverage works the same way where Kaiser sells a weight-loss rider, but the clinical steps can be longer. The Northwest asks for two older pills and then a semaglutide trial before it approves Zepbound. Humana members are almost all on Medicare, so for them the $50 Bridge is the main route. Blue Cross rules depend on which Blue you have. See our guides to Aetna, UnitedHealthcare, Cigna, Blue Cross Blue Shield and Humana.
What can I do if Kaiser won’t pay?
Paying cash outside Kaiser is the usual route. Your Kaiser coverage for everything else stays the same.
- Several telehealth providers sell brand-name GLP-1s for cash, including the Wegovy pill and Foundayo, and the makers sell some doses directly. See GLP-1 cost without insurance for every channel.
- Compounded semaglutide or tirzepatide costs less, from about $99 a month month-to-month, but it isn’t FDA-approved. The FDA explains its concerns. Compare compounded GLP-1 prices or read FDA-approved vs. compounded GLP-1s.
- If you see an outside clinician, tell your Kaiser care team what you’re taking, so your records and other prescriptions stay accurate.
